Metropolitan Life Insurance Company (MetLife)’s Protolabs PRLB Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio PRLB Stock Details PRLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,397	Closed	-$49.9K	–	1601
2024 Q1	$49.9K	Sell	1,397 -189	-12%	-$6.82K	﹤0.01%	1405
2023 Q4	$61.8K	Hold	1,586	–	–	﹤0.01%	1330
2023 Q3	$41.9K	Buy	1,586 +191	+14%	+$5.77K	﹤0.01%	1509
2023 Q2	$48.8K	Sell	1,395 -185	-12%	-$5.89K	﹤0.01%	1431
2023 Q1	$52.4K	Hold	1,580	–	–	﹤0.01%	1360
2022 Q4	$40.3K	Hold	1,580	–	–	﹤0.01%	1601
2022 Q3	$57.6K	Hold	1,580	–	–	﹤0.01%	1358
2022 Q2	$75.6K	Sell	1,580 -231	-13%	-$10.7K	﹤0.01%	1234
2022 Q1	$95.8K	Sell	1,811 -5,058	-74%	-$266K	﹤0.01%	1222
2021 Q4	$353K	Sell	6,869 -860	-11%	-$50.7K	﹤0.01%	1646
2021 Q3	$515K	Hold	7,729	–	–	0.01%	1442
2021 Q2	$710K	Buy	7,729 +495	+7%	+$48.8K	0.01%	1275
2021 Q1	$881K	Sell	7,234 -253	-3%	-$42.1K	0.01%	1047
2020 Q4	$1.15M	Sell	7,487 -26	-0.3%	-$3.67K	0.02%	785
2020 Q3	$973K	Sell	7,513 -534	-7%	-$70.2K	0.02%	759
2020 Q2	$905K	Hold	8,047	–	–	0.02%	793
2020 Q1	$613K	Buy	8,047 +52	+0.7%	+$4.82K	0.01%	940
2019 Q4	$812K	Sell	7,995 -701	-8%	-$69.5K	0.01%	1023
2019 Q3	$888K	Hold	8,696	–	–	0.02%	921
2019 Q2	$1.01M	Hold	8,696	–	–	0.02%	887
2019 Q1	$914K	Sell	8,696 -155	-2%	-$17.4K	0.02%	932
2018 Q4	$998K	Buy	8,851 +131	+2%	+$16.2K	0.02%	810
2018 Q3	$1.41M	Hold	8,720	–	–	0.02%	728
2018 Q2	$1.04M	Buy	8,720 +888	+11%	+$109K	0.02%	905
2018 Q1	$921K	Buy	7,832 +199	+3%	+$22.5K	0.01%	940
2017 Q4	$786K	Sell	7,633 -9,591	-56%	-$861K	0.01%	1020
2017 Q3	$1.38M	Sell	17,224 -211	-1%	-$15.3K	0.01%	1088
2017 Q2	$1.17M	Hold	17,435	–	–	0.01%	1154
2017 Q1	$891K	Hold	17,435	–	–	0.01%	1290
2016 Q4	$895K	Hold	17,435	–	–	0.01%	1354
2016 Q3	$1.04M	Sell	17,435 -474	-3%	-$27.3K	0.01%	1253
2016 Q2	$1.03M	Buy	17,909 +1,459	+9%	+$97.4K	0.01%	1240
2016 Q1	$1.27M	Buy	16,450 +17	+0.1%	+$1.1K	0.01%	1067
2015 Q4	$1.05M	Hold	16,433	–	–	0.01%	1161
2015 Q3	$1.1M	Sell	16,433 -205	-1%	-$14.6K	0.01%	1144
2015 Q2	$1.12M	Sell	16,638 -815	-5%	-$57.5K	0.01%	1213
2015 Q1	$1.22M	Hold	17,453	–	–	0.01%	1100
2014 Q4	$1.17M	Hold	17,453	–	–	0.01%	1232
2014 Q3	$1.2M	Hold	17,453	–	–	0.01%	1172
2014 Q2	$1.43M	Buy	17,453 +3,884	+29%	+$263K	0.01%	1139
2014 Q1	$918K	Hold	13,569	–	–	0.01%	1409
2013 Q4	$966K	Hold	13,569	–	–	0.01%	1351
2013 Q3	$1.04M	Hold	13,569	–	–	0.01%	1263
2013 Q2	$882K	Buy	+13,569	New	+$729K	0.01%	1308

Other funds holding PRLB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s PRLB Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Protolabs (PRLB) in Q2 2024, closing a stake of 1,397 shares — an estimated $49.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PRLB in Q2 2013 and held it in 44 quarters. The position peaked at $1.43M in Q2 2014. 204 funds tracked by Wall St. Rank hold PRLB as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Protolabs position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,397 Protolabs shares in Q2 2024, an estimated $49.9K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Protolabs in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Protolabs position peaked at $1.43M in Q2 2014.
204 funds tracked by Wall St. Rank held Protolabs as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.